Handok to sell Amaryl-M firstly to overseas market in March.

Handok plans to supply Amaryl-M, an anti-hyperglycemic drug developed by Handok Central Research Institute, to the overseas markets from coming March this year, mainly to Peru for Amaryl-M 1/250mg (glymepyride 1mg plus metformin 250mg) and Amaryl 2/500mg (glymeyride 2mg plus metformin 500mg) as much as 82 million won worth.

Amaryl-M may improve to secrete more insulin in the body as well as ...